
Ivapace 15mg Tablet SR
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Ivabradine (15mg)
Overview Ivapace 15mg Tablet SR
Sustained-release Ivapace 15mg tablets manage angina pectoris (chest pain stemming from heart issues) and chronic congestive heart failure. Its mechanism involves improving cardiac efficiency via reduced heart rate, thus mitigating chest discomfort and hospitalization risk in heart failure patients. Dosage is condition-specific. Given the typically lifelong nature of angina and heart failure treatment, discontinuation requires physician consultation. Administer daily at the same time, with food. Overdosage may cause bradycardia (excessively slow heart rate), fatigue, and shortness of breath; seek immediate medical attention in such cases. Common, often transient, side effects include visual disturbances, bradycardia, hypertension, atrial fibrillation, dizziness, blurred vision, and electrocardiogram alterations. Serious adverse events like syncope (fainting) and significant cardiac rhythm changes necessitate prompt medical intervention. Refrain from driving until the drug's effects are known. Contraindicated in individuals with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, severely low blood pressure, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of Ivapace 15mg Tablet SR
Managing angina pectoris and heart failure.
Major Benefits of Ivapace 15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. It is recommended to take the Ivapace 15mg SR tablet with food.
Common Side effects of Ivapace 15mg Tablet SR:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivapace 15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivapace 15mg Sustained-Release Tablet should be administered with a meal.
How Ivapace 15mg Tablet SR works:
Slow-release Ivapace 15mg tablets reduce heart rate, thereby decreasing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivapace 15mg Tablet SR may be unsafe; seek medical advice before combining them.
PregnancyUNSAFE
The extended-release 15mg Ivapace tablet poses a substantial risk during pregnancy. Pregnant women should consult their physician immediately, as research in both animals and humans indicates considerable harm to the fetus.
Breast feedingUNSAFE
Extended-release Ivapace 15mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Ivapace 15mg Tablet SR. This medication can induce transient visual disturbances, primarily phosphenes. Night driving, in particular, should consider the potential for such light flashes.
KidneyCAUTION
Exercise caution when prescribing Ivapace 15mg Tablet SR to individuals with severely impaired renal function. Dosage modification of Ivapace 15mg Tablet SR may be necessary. Physician consultation is recommended. Data regarding the use of Ivapace 15mg Tablet SR in patients with severe kidney disease is limited.
LiverCAUTION
Patients with liver impairment should use Ivapace 15mg SR tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Ivapace 15mg SR tablets; consult a physician for guidance.
What if you forget to take Ivapace 15mg Tablet SR :
Omit any missed dose of Ivapace 15mg Tablet SR and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ivapace 15mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | Sinoatrial node I<sub>f</sub> sodium channel blockers |
